NeuroSense Therapeutics Ltd. Proceeds From Exercise Of Warrants
NeuroSense Therapeutics Ltd. (NRSN) reported Proceeds From Exercise Of Warrants of $823.00 thousand for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-04.
Discontinued › Cash Flow › Financing Activities
ifrs-full:ProceedsFromExerciseOfWarrants · last filed 2024-04-04
| Period end | Proceeds From Exercise Of Warrants 6 month | Proceeds From Exercise Of Warrants 12 month |
|---|---|---|
| 2023-12-31 | $823.00K 20-F · filed 2024-04-04 | |
| 2022-12-31 | $444.00K 20-F · filed 2024-04-04 | |
| 2022-06-30 | $444.00K 6-K/A · filed 2023-01-19 |